2018 – Page 14 – Policy & Medicine

Senate Aging Committee Takes on Alzheimer’s

Congress and FDA address Over the Counter Drugs

Is British Columbia Set to Follow Ontario in Canadian Pharmaceutical Transparency?

New Research Reveals Doctors Who Maintain ABIM Certification Are More Likely to Meet Quality Metrics

FDA Releases Draft Guidance on Indications and Usage Labeling Sections

2019 CMS Proposed Physician Fee Schedule Includes Serious Cuts to Medicare Part B Drug Reimbursement

Lawsuit Filed Over New York Opioid Tax and Stewardship Law

FDA Releases Final Guidance on Medical Product Communications and Labeling

Consultant Found Guilty Using CMS Data for Insider Trading

Subcommittee on Health to Hold Hearing on Reforming the 340B Drug Pricing Program